			Home About us Contact

Site Activation (site + activation)

Distribution by Scientific Domains

Polymers and Materials Science	50%
Life Sciences	33%

Selected Abstracts

Chain Length Distributions of Polyolefins Made in Stopped-Flow Reactors for Non-Instantaneous Site Activation

MACROMOLECULAR REACTION ENGINEERING, Issue 2 2008
João B. P. Soares
Abstract We developed an analytical solution to describe how the chain length distribution (CLD) of polymers made with coordination polymerization catalysts vary as a function of time for very short polymerizations considering non-instantaneous site activation. This solution is an extension of our previous analytical expression for instantaneous site activation. We validated the analytical solution with dynamic Monte Carlo simulation and obtained excellent agreement. Simulation results indicate that, unless the catalyst activation rate is much lower than the propagation rate, it will have only a minor effect on the initial shape of the CLD of polymers made in stopped-flow reactors (SFR). We also show how incorrect polymerization kinetic parameters may be estimated when assuming instantaneous site activation when this hypothesis is not applicable to the polymerization data under investigation. [source]

Genetic loss of D-amino acid oxidase activity reverses schizophrenia-like phenotypes in mice

GENES, BRAIN AND BEHAVIOR, Issue 1 2010
V. Labrie
Reduced function of the N -methyl- d -aspartate receptor (NMDAR) has been implicated in the pathophysiology of schizophrenia. The NMDAR contains a glycine binding site in its NR1 subunit that may be a useful target for the treatment of schizophrenia. In this study, we assessed the therapeutic potential of long-term increases in the brain levels of the endogenous NMDAR glycine site agonist D-serine, through the genetic inactivation of its catabolic enzyme D-amino acid oxidase (DAO) in mice. The effects of eliminating DAO function were investigated in mice that display schizophrenia-related behavioral deficits due to a mutation (Grin 1D481N) in the NR1 subunit that results in a reduction in NMDAR glycine affinity. Grin 1D481N mice show deficits in sociability, prolonged latent inhibition, enhanced startle reactivity and impaired spatial memory. The hypofunctional Dao 1G181R mutation elevated brain levels of D-serine, but alone it did not affect performance in the behavioral measures. Compared to animals with only the Grin 1D481N mutation, mice with both the Dao1G181R and Grin 1D481N mutations displayed an improvement in social approach and spatial memory retention, as well as a reversal of abnormally persistent latent inhibition and a partial normalization of startle responses. Thus, an increased level of D-serine resulting from decreased catalysis corrected the performance of mice with deficient NMDAR glycine site activation in behavioral tasks relevant to the negative and cognitive symptoms of schizophrenia. Diminished DAO activity and elevations in D-serine may serve as an effective therapeutic intervention for the treatment of psychiatric symptoms. [source]

Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy,

HEPATOLOGY, Issue 1 2007
Gudrun Schneider
Intrahepatic cholestasis of pregnancy (ICP) is defined as pruritus and elevated bile acid serum concentrations in late pregnancy. Splicing mutations have been described in the multidrug resistance p-glycoprotein 3 (MDR3, ABCB4) gene in up to 20% of ICP women. Pedigrees studied were not large enough for linkage analysis. Ninety-seven family members of a woman with proven ICP were asked about pruritus in earlier pregnancies, birth complications and symptomatic gallstone disease. The familial cholestasis type 1 (FIC1, ATP8B1) gene, bile salt export pump (BSEP, ABCB11) and MDR3 gene were analyzed in 55 relatives. We identified a dominant mode of inheritance with female restricted expression and a new intronic MDR3 mutation c.3486+5G>A resulting in a 54 bp (3465,3518) inframe deletion via cryptic splicing site activation. Linkage analysis of the ICP trait versus this intragenic MDR3 variant yielded a LOD score of 2.48. A Bayesian analysis involving MDR3, BSEP, FIC1 and an unknown locus gave a posterior probability of >0.9966 in favor of MDR3 as causative ICP locus. During the episode of ICP the median ,-glutamyl transpeptidase (,-GT) activity was 10 U/l (95% CI, 6.9 to 14.7 U/l) in the index woman. Four stillbirths were reported in seven heterozygous women (22 pregnancies) and none in five women (14 pregnancies) without MDR3 mutation. Symptomatic gallstone disease was more prevalent in heterozygous relatives (7/21) than in relatives without the mutation (1/34), (P = 0.00341). Conclusion: This study demonstrates that splicing mutations in the MDR3 gene can cause ICP with normal ,-GT and may be associated with stillbirths and gallstone disease. (HEPATOLOGY 2007;45:150,158.) [source]

Phenotypic consequences of branch point substitutions,

HUMAN MUTATION, Issue 8 2006
Jana Královi
Abstract The branch point sequence (BPS) is a conserved splicing signal important for spliceosome assembly and lariat intron formation. BPS mutations may result in aberrant pre-mRNA splicing and genetic disorders, but their phenotypic consequences have been difficult to predict, largely due to a highly degenerate nature of the BPS consensus. Here, we have examined the splicing pattern of nine reporter pre-mRNAs that have previously been shown to give rise to human hereditary diseases as a result of single-nucleotide substitutions in the predicted BPS. Increased exon skipping and intron retention observed in vivo were recapitulated for each mutated pre-mRNA, but the reproducibility of cryptic splice site activation was lower. BP mutations in reporter pre-mRNAs frequently induced aberrant 3, splice sites and also activated a cryptic 5, splice site. Systematic mutagenesis of BP adenosines showed that in most pre-mRNAs, the expression of canonical transcripts was lower for BP transitions than BP transversions. Differential splicing outcome for transitions vs. transversions was abrogated or reduced if introns were truncated to 200 nt or less, suggesting that the nature of the BP residue is less critical for interactions across very short introns. Together, these results improve prediction of phenotypic consequences of point mutations upstream of splice acceptor sites and suggest that the overrepresentation of disease-causing adenosine-to-guanosine BP substitutions observed in Mendelian disorders is due to more profound defects of gene expression at the level of pre-mRNA splicing. Hum Mutat 27(8), 803,813, 2006. © 2006 WileyLiss, Inc. [source]

Kinetic behavior of ethylene/1-hexene copolymerization in slurry and solution reactors

JOURNAL OF POLYMER SCIENCE (IN TWO SECTIONS), Issue 11 2005
Long Wu
Abstract The copolymerization of ethylene and 1-hexene over a spherical polymer/MgCl2 -supported TiCl4 catalyst was studied as a function of the polymerization temperature from 40 to 100 °C in a slurry reactor and from 120 to 200 °C in a solution reactor with triethylaluminum (TEA) as a cocatalyst (1.0,6.8 mmol). The activities increased from 40 to 80 °C and then declined monotonically with increases in the temperature during the slurry and solution polymerizations. The kinetic behavior in the slurry and solution operations was described by the same rate expression. The modeling results indicated that the catalyst had at least two different types of catalytic sites; one site was responsible for the acceleration,decay nature of the activity profiles, whereas the second site resulted in long-term activity. The apparent activation energy for site activation in the slurry operation was 69.9 kJ/mol; no activation energies for site activation could be estimated for the solution operation because the activation process was essentially instantaneous at the higher temperatures. The activation energies for deactivation were 100.3 kJ/mol for the slurry operation and 31.2 kJ/mol for the solution operation. The responses to TEA were similar for the slurry and solution operations; the rates increased with increasing amounts of TEA between 1.0 and 3.4 mmol and then decreased with larger amounts of TEA. © 2005 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 43: 2248,2257, 2005 [source]